首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >A Scoping Review: Life Cycle, Diagnosis and Current Treatment Strategies of Coronavirus Disease (COVID-19) Outbreak
【24h】

A Scoping Review: Life Cycle, Diagnosis and Current Treatment Strategies of Coronavirus Disease (COVID-19) Outbreak

机译:范围审查:冠状病毒病的生命周期,诊断和当前治疗策略(Covid-19)爆发

获取原文

摘要

In December 2019, the erupt of the novel coronavirus ailment (COVID-19) in China spread far and wide, transforming into an emergency of critical overall concern. SARS-CoV-2 ailment causes gatherings of extraordinary respiratory affliction like genuine serious respiratory issue coronavirus. Human-to-human transmission through dabs, contaminated hands or surfaces has been depicted, with bring forth times of 2-14 days. Early investigation, separate, and consistent prescriptions are essential to fix patients. Prescriptions, including antiviral pros, chloroquine and hydroxychloroquine, corticosteroids, antibodies, picking up quality plasma transfusion and vaccinations, are analyzed in this article. Likewise, enlisted preliminaries examining treatment alternatives for COVID-19 contamination. COVID-19 is containing single abandoned (positive-sense) RNA related with a nucleoprotein inside a capsid included grid protein. A common CoV contains in any event six ORFs in its genome. All the basic and frill proteins are deciphered from the sgRNAs of CoVs. Four fundamental basic proteins are encoded by ORFs 10, 11 on the 33% of the genome close to the 30-end. The hereditary and phenotypic structure of COVID-19 in pathogenesis is significant. The transmission of COVID-19 disease starting with one individual then onto the next brought about the segregation of patients who were in this manner given an assortment of medicines. To screen the present flare-up, strong advances have been taken the world over to decrease the transmission of COVID-19 disease especially restricting global and household flights, accepting lockdowns in defenseless regions, social separating and so on. No clinically affirmed antiviral medication or antibody against COVID-19 is accounted for yet. Notwithstanding, in clinical preliminaries, barely any wide range antiviral medications were assessed against COVID-19 contamination which brought about clinical recuperation.
机译:2019年12月,中国在中国的新型冠状病毒疾病(Covid-19)爆发了远远广泛,转变为关键整体关注的紧急情况。 SARS-COV-2疾病导致非凡的呼吸痛苦的聚集,如真正的严重呼吸问题冠状病毒。通过DAB,污染的手或表面的人对人体传输,提出了2-14天的时间。早期调查,分开和一致的处方对于修复患者至关重要。在本文中分析了处方,包括抗病毒专利,氯喹和羟氯喹,皮质类固醇,抗体,拾起质量等离子体输血和疫苗接种。同样,入伍预备审查了Covid-19污染的处理替代品。 Covid-19含有与衣壳内的核蛋白有关的单一废弃(阳性意义)RNA包括胶合蛋白。常见的COV在其基因组中的任何事件中含有六个ORF。所有的基本和散热蛋白都从COV的SGRNA译成。四个基本碱基蛋白质由ORF 10,11编码,在33%的基因组上接近30端。 Covid-19在发病机制中的遗传和表型结构是显着的。在一个单独的患者中,患有一个单独的药物的患者的偏解析的患者的分离术中的Covid-19疾病的传播。为了筛选目前的爆发,已经采取了强劲的进展,以减少Covid-19疾病的传播,特别是限制全球和家庭航班,接受裁员区域,社会分离等锁定。没有临床肯定的抗病毒药物或抗Covid-19的抗体。尽管如此,在临床预备中,勉强任何广泛的抗病毒药物都是针对Covid-19污染评估的,这引起了临床疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号